ScoreWhy is Incyte Corp. ?
1
High Management Efficiency with a high ROE of 13.05%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 14.03% and Operating profit at 53.05%
4
Positive results in Dec 25
- OPERATING CASH FLOW(Y) Highest at USD 1,413.5 MM
- ROCE(HY) Highest at 29.87%
- RAW MATERIAL COST(Y) Fallen by 0.22% (YoY)
5
With ROE of 17.66%, it has a fair valuation with a 4.03 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 37.17%, its profits have risen by 2104.8% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Incyte Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Incyte Corp. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Incyte Corp.
34.99%
1.81
35.03%
S&P 500
20.78%
0.92
19.35%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.03%
EBIT Growth (5y)
53.05%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
1.03
Tax Ratio
93.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
43.95%
ROE (avg)
13.05%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
4.03
EV to EBIT
14.50
EV to EBITDA
13.29
EV to Capital Employed
8.19
EV to Sales
3.14
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
56.51%
ROE (Latest)
17.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1,413.5 MM
ROCE(HY)
Highest at 29.87%
RAW MATERIAL COST(Y)
Fallen by 0.22% (YoY
NET SALES(Q)
Highest at USD 1,506.84 MM
NET PROFIT(Q)
At USD 336.13 MM has Grown at 69.24%
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Incyte Corp.
Operating Cash Flow
Highest at USD 1,413.5 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 1,506.84 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 1,506.84 MM has Grown at 27.84%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
At USD 336.13 MM has Grown at 69.24%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by 0.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Incyte Corp.
Non Operating Income
Highest at USD 0.14 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
